Polen Capital started to build up the position in Lemaitre Vascular in Q1 2018 and continued to invest until Q2 2020. Since then they sold 93.5 Thousand shares. The investor sold all their shares in Q3 2020 and doesn't own any shares in Lemaitre Vascular anymore.
On December 27, it was revealed in an SEC filing that George LeMaitre , Chairman and CEO at LeMaitre Vascular (NASDAQ: LMAT ) executed a significant exercise...
LeMaitre missed top line estimates secondary to FX headwinds and market challenges. Read more to learn why we reaffirm our Buy rating on LMAT stock.
https://www.investing.com/news/pro/lemaitre-vascular-pt-lowered-to-46-at-roth-capital-432SI-2935669